Crown Bioscience, Inc. (Taicang)
Records under this name other than the patents Crown Bioscience, Inc. (Taicang) holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Showing 1 to 3 of 3 · Back to Crown Bioscience, Inc. (Taicang)
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,695,175 | Highly selective c-Met inhibitors as anticancer agents Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,020,494 | Animal Models for Nonalcoholic Fatty Liver Disease Formerly held In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 9,921,222 | Histological markers for identifying non-small cell lung carcinoma patients for treatment with an anti-EGFR drug Lapsed on the fee record Ended Mar 20, 2022 · From the USPTO record | Lapsed on the fee record | Ended Mar 20, 2022 | From the USPTO record |